Pobieranie prezentacji. Proszę czekać

Pobieranie prezentacji. Proszę czekać

Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study. by Sergiusz Markowicz,

Podobne prezentacje


Prezentacja na temat: "Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study. by Sergiusz Markowicz,"— Zapis prezentacji:

1 Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study. by Sergiusz Markowicz, Anna Jakubowska-Mucka, Marzena Biernacka, Grzegorz Rymkiewicz, Anna Borawska, Irena Federowicz, Danuta Rozewska, Maria Sawadro-Rochowska, Hanna Polowniak-Pracka, Michal Szymczyk, Henryk Skurzak, Zygmunt Pojda, and Jan Walewski Blood Volume 108(11): November 16, 2006 ©2006 by American Society of Hematology

2 Disease and treatment course of a representative case.
Sergiusz Markowicz et al. Blood 2006;108:5187 ©2006 by American Society of Hematology


Pobierz ppt "Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study. by Sergiusz Markowicz,"

Podobne prezentacje


Reklamy Google